Skip to main content

Advertisement

Table 5 Urinary concentrations of phthalate metabolites and bisphenol A in polycystic ovary syndrome (PCOS) case-patients and controls

From: Exploring the potential association between brominated diphenyl ethers, polychlorinated biphenyls, organochlorine pesticides, perfluorinated compounds, phthalates, and bisphenol a in polycystic ovary syndrome: a case–control study

Agents   Geometric mean concentration (μg/L) Creatinine-adjusted geometric mean concentration (μg/g creatinine)
Phthalates Phthalate metabolites measured PCOS case-patients PCOS control-patients PCOS case-patients PCOS control-patients
Butylbenzyl phthalate (BBzP) Monobenzyl phthalate (mBzP) 4.7 9.0 7.5 11.7a
Di-n-butyl phthalate (DBP) Mono-n-butyl phthalate (mBP) 15.3 24.8 17.7 23.2
Diethyl phthalate (DEP) Monoethyl phthalate (mEP) 103.7 138.3 181.1 195.8
Di-isodecyl phthalate (DiDP) Mono(carboxynonyl) phthalate (mCNP) 3.2 3.0 3.6 2.6
Di-isononyl phthalate (DiNP) Mono(carboxyoctyl) phthalate (mCOP) 6.7 9.0 7.8 8.4
Di-n-octyl phthalate (DOP) Mono-3-carboxypropyl phthalate (mCPP) 2.4 3.6 2.8 3.4
Di-2-ethylhexyl phthalate (DEHP) Mono-2-ethyl-5-carboxypentyl phthalate (mECPP) 41.5 43.2 47.9 40.4
  Mono-2-ethyl-5-hydroxyhexyl phthalate (mEHHP) 23.7 28.3 27.3 26.4
  Mono-2-ethylhexyl phthalate (mEHP) 3.3 4.0 3.2 3.5
  Mono-2-ethyl-5-oxohexyl phthalate (mEOHP) 14.0 17.4 16.2 16.3
Di-isobutyl phthalate (DiBP) Mono-isobutyl phthalate (miBP) 6.0 8.7 7.0 8.2
Phenols      
bisphenol A (BPA)   1.6 2.1 1.6 1.9
  1. ap = 0.02 where controls have higher mBzP urinary concentrations than case-patients.